Our data also identified MDS-associated transcriptional alterations that may trigger the development of the disease, such as upregulation of DDIT3, a member of the C/EBP family of TFs, which is involved in functions such as cellular differentiation and proliferation, control of apoptosis and inflammatory processes. This evidence concerns the gene DDIT3 and myelodysplastic syndrome.